A5036766039- Urinary Bladder and Prostate Research
- Prostate Cancer Diagnosis and Treatment
- Pelvic floor disorders treatments
- Urological Disorders and Treatments
- Hormonal and reproductive studies
- Urologic and reproductive health conditions
- Sexual function and dysfunction studies
- Bladder and Urothelial Cancer Treatments
- Urinary Tract Infections Management
- Kidney Stones and Urolithiasis Treatments
- Prostate Cancer Treatment and Research
- Connexins and lens biology
- Medical Device Sterilization and Disinfection
- Sexual Differentiation and Disorders
- Pediatric Urology and Nephrology Studies
- Pain Management and Treatment
- Ureteral procedures and complications
- Male Reproductive Health Studies
- Surgical Simulation and Training
- Laser Applications in Dentistry and Medicine
- Solid State Laser Technologies
- Hemostasis and retained surgical items
- Laser-induced spectroscopy and plasma
- Genital Health and Disease
- Vascular anomalies and interventions
Tauranga Hospital
2016-2025
University of Auckland
2014-2025
Urology Bay of Plenty
2015-2024
American Urological Association
2003-2023
Evidence (Italy)
2023
Michigan Department of Education
2023
Queen Alexandra Hospital
2020
Men's Health Boston
2018
University of Catania
2018
Faculty of Media
2016
To assess the durability of holmium laser enucleation prostate in comparison to transurethral resection (TURP).Patients were enrolled present study between June 1997 and December 2000 followed per protocol. All patients urodynamically obstructed with a volume 40 200 mL. At long-term follow-up, variables assessed included Benign Prostatic Hyperplasia Impact Index (BPHII), International Continence Society Short Form Male questionnaire (ICSmale-SF) Erectile Function (IIEF). Adverse events,...
We compared the safety and efficacy of Aquablation transurethral prostate resection for treatment lower urinary tract symptoms related to benign prostatic hyperplasia.In a double-blind, multicenter, prospective, randomized, controlled trial 181 patients with moderate severe hyperplasia underwent or Aquablation. The primary end point was reduction in International Prostate Symptom Score at 6 months. development Clavien-Dindo persistent grade 1, 2 higher operative complications.Mean total time...
The preliminary experience with 64 patients who have undergone HoLEP combined intravesical morcellation is presented. mean preoperative prostate volume was 75.3 cc. laser time 46.9 minutes and the morcellator a further 10.5 minutes. A total of 35.5 g tissue obtained, 93% were discharged day after their surgery without catheter. American Urological Association Symptom Score at 1 month 8.6 peak flow rate 23.4 mL/sec. This combination procedures allows glands virtually any size to be safely...
No AccessJournal of UrologyCLINICAL UROLOGY: Original Articles1 Oct 2003A Randomized Trial Comparing Holmium Laser Enucleation the Prostate with Transurethral Resection for Treatment Bladder Outlet Obstruction Secondary to Benign Prostatic Hyperplasia in Large Glands (40 200 Grams) A.H. H. TAN, P.J. GILLING, K.M. KENNETT, C. FRAMPTON, A.M. WESTENBERG, and M.R. FRAUNDORFER TANA.H. TAN , GILLINGP.J. GILLING KENNETTK.M. KENNETT FRAMPTONC. FRAMPTON WESTENBERGA.M. WESTENBERG FRAUNDORFERM.R. View...
Study Type – Therapy (RCT) Level of Evidence 1b What’s known on the subject? and What does study add? Both dutasteride finasteride inhibit type 2 5α‐reductase, dominant form 5α‐reductase in benign prostatic tissue, making these effective treatments for BPH. In comparison with finasteride, has a longer half‐life leads to greater more consistent suppression serum intraprostatic DHT. EPICS is currently only prospective, randomized, double‐blind vs BPH endpoints conducted than few months. Over...
To assess the safety and feasibility of aquablation in a first-in-man study. Aquablation is novel minimally invasive water ablation therapy combining image guidance robotics (AquaBeam(®) ) for targeted heat-free removal prostatic tissue men with lower urinary tract symptoms (LUTS) secondary to benign hyperplasia (BPH).A prospective, non-randomised, single-centre trial aged 50-80 years moderate-to-severe LUTS was conducted. Under real-time image-based ultrasonic guidance, AquaBeam technology...
The high-powered holmium:YAG laser can be used for incision, ablation and resection of the prostate. technique holmium prostate is compared to transurethral prostatic surgical management benign hyperplasia in this prospective randomized study.A total 120 urodynamically obstructed cases were or resection. All eligible patients assessed preoperatively at 3 weeks, 3, 6 12 months postoperatively with an American Urological Association symptom score, peak urinary flow rate, questionnaires...
The holmium wavelength (2.1 microns) can be used for incision, ablation, and resection of prostate tissue. Four different techniques the surgical management benign hyperplasia (BPH) have evolved using laser either alone or in combination with Nd:YAG energy. results 650 patients undergoing these procedures are presented. has been most recently to perform a transurethral 381 date. This procedure appears efficient way removal obstructing prostatic
No AccessJournal of Urology1 Dec 1993Major Renal Lacerations with a Devitalized Fragment following Blunt Abdominal Trauma: A Comparison between Nonoperative (Expectant) Versus Surgical Management D.A. Husmann, P.J. Gilling, M.O. Perry, J.S. Morris, and T.B. Boone HusmannD.A. Husmann , GillingP.J. Gilling PerryM.O. Perry MorrisJ.S. Morris BooneT.B. View All Author Informationhttps://doi.org/10.1016/S0022-5347(17)35892-5AboutPDF ToolsAdd to favoritesDownload CitationsTrack...
It has previously been shown that holmium laser resection of the prostate (HoLRP) is superior to transurethral (TURP) with regard perioperative morbidity and equivalent TURP in short term. We present long-term results a randomized, prospective trial comparing HoLRP since information regarding durability prostatectomy lacking literature date.A total 120 patients urodynamic obstruction were randomized (April 1996 August 1997) into 2 comparable groups assigned or TURP. All assessed...
We sought to establish the safety and effectiveness of aquablation, a novel, image guided, robotic assisted, water jet tissue ablation technology, for treatment benign prostatic hyperplasia.We performed prospective, single arm, multicenter trial at total 3 centers in Australia New Zealand with 1-year followup. Participants were men 50 80 years old moderate severe lower urinary tract symptoms as determined by urodynamics. All patients underwent aquablation under guidance. Primary end points...